HALOZYME THERAPEUTICS INC - NOTE 0.250% 3/0

Historical Holders from Q1 2022 to Q1 2025

CUSIP: 40637HAD1
Type / Class: Debt / NOTE 0.250% 3/0
All holders as of December 31, 2024: Q4 2024
Principal, excl. options: 713M
Holdings value: $683M
% of all portfolios: 0.001%
Grand Portfolio weight change: +0%
Number of holders: 57
Number of buys: 21
Number of sells: -25
Average Value change %: 0%
Average buys %: +0%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of HALOZYME THERAPEUTICS INC - NOTE 0.250% 3/0

Period	Principal	Value	Change	Price	Investors
2025 Q1	$4.1M	$4.31M	-$43.9K	$1.05	4
2024 Q4	$713M	$683M	+$31.1M	$0.95	57
2024 Q3	$686M	$688M	-$134M	$1.00	53
2024 Q2	$833M	$796M	+$12.8M	$0.95	57
2024 Q1	$819M	$727M	-$743K	$0.89	60
2023 Q4	$631M	$549M	+$12M	$0.86	62
2023 Q3	$615M	$523M	+$8.64M	$0.85	63
2023 Q2	$607M	$506M	+$19.2M	$0.83	64
2023 Q1	$649M	$551M	+$84.3M	$0.85	61
2022 Q4	$485M	$488M	+$18.5M	$0.97	54
2022 Q3	$479M	$386M	-$211M	$0.85	47
2022 Q2	$713M	$600M	+$140M	$0.88	50
2022 Q1	$543M	$460M	+$460M	$0.88	45